JAPAN CARDIOVASCULAR RESEARCH FOUNDATION
π―π΅Japan
Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2015-12-30
- Last Posted Date
- 2015-12-30
- Lead Sponsor
- Japan Cardiovascular Research Foundation
- Target Recruit Count
- 2200
- Registration Number
- NCT02642419
- Locations
- π―π΅
Japan Cardiovascular Research Foundation, Suita, Osaka, Japan
GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence
- Conditions
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2015-12-17
- Lead Sponsor
- Japan Cardiovascular Research Foundation
- Target Recruit Count
- 5000
- Registration Number
- NCT02633982
- Locations
- π―π΅
Japan Cardiovascular Research Foundation, Suita, Osaka, Japan
RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke
- Conditions
- Interventions
- First Posted Date
- 2014-05-02
- Last Posted Date
- 2014-05-02
- Lead Sponsor
- Japan Cardiovascular Research Foundation
- Target Recruit Count
- 2000
- Registration Number
- NCT02129920
- Locations
- π―π΅
Japan Cardiovascular Research Foundation, Suita, Osaka, Japan
Cilostazol Stroke Prevention Study for Antiplatelet Combination
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2019-03-28
- Lead Sponsor
- Japan Cardiovascular Research Foundation
- Target Recruit Count
- 1884
- Registration Number
- NCT01995370
- Locations
- π―π΅
Japan Cardiovascular Research Foundation, Osaka, Japan
Β© Copyright 2024. All Rights Reserved by MedPath